University Trustees, Student Leaders Honor Pestello Legacy
06/04/2025
The Saint Louis University Board of Trustees has named President Fred P. Pestello, Ph.D., president emeritus, effective July 1, in recognition of his transformational 11-year tenure as SLU’s first lay president.
Emeritus status for a college president is a prestigious — and typically lifelong — designation that honors an outgoing leader’s legacy, service and contributions to a university community and beyond.
In its resolution conferring the emeritus title, SLU’s Board highlighted Pestello’s values-based leadership and the many ways he helped transform the University, from record-setting enrollment and fundraising efforts to major construction projects, an expanded research enterprise, and community partnerships that have reimagined Midtown St. Louis.
Also in May, SLU’s Student Government Association established a new undergraduate scholarship to honor the leadership of Dr. Pestello and his spouse, Fran. The Drs. Fred and Fran Pestello Legacy of Leadership Award will recognize one outstanding undergraduate student each year who:
- Upholds SLU’s Catholic, Jesuit mission through education, ethics, and service
- Maintains academic excellence
- Actively engages in community service in St. Louis
“The creation of this award is a tribute to the years Drs. Pestello have given to students and their dedication to shared governance,” said outgoing SGA president, Reueline Arulanandam, (PH ’25). “It is intentionally designed to remember their incredible legacy and honor students who are making their own. With this award, we honor them and hope to encourage many students to come to take after their example of leadership.”
To contribute to the Fred and Fran Pestello Legacy of Leadership Award fund, visit the Giving to SLU website.
Latest Newslink
- SLU Supports St. Louis by Hosting City's Tornado Relief CenterIn the weeks following a devastating tornado that tore through St. Louis on May 16, hundreds of households have turned to a centralized Disaster Assistance Center (DAC) at Chaifetz Arena for assistance.
- Persistence Pays Off for Fulbright Award RecipientAnuj Gandhi is a Fulbright Scholar. A year after being chosen as an alternate, Gandhi has been chosen for a Fulbright-Nehru Student Research Award. With the Award, the recent Saint Louis University graduate intends to "investigate how globalization-based acculturation influences Indian young adults' attitudes toward mental health and treatment options."
- Pestellos Honored With Honorary Street NameA stretch of Laclede Avenue that has undergone major development since President Fred P. Pestello, Ph.D., and First Lady Fran Pestello, Ph.D., arrived at Saint Louis University 11 years ago now has a new name.
- Disaster Assistance Center Opens to the Community in Response to the May 16 TornadoThe City of St. Louis, in partnership with the Missouri State Emergency Management Agency and Saint Louis University, opened a Disaster Assistance Center (DAC) on Monday, June 9, to serve as a central space for tornado-affected residents to connect with agencies offering guidance, resources, and assistance related to recovery and long-term support. The DAC will take place inside Chaifetz Arena.
- St. Louis Magazine Salutes SLU's Top Nursing EducatorsFour nursing educators in Saint Louis University's Trudy Busch Valentine School of Nursing have been honored with a St. Louis Magazine's 2025 Excellence in Nursing Award. This recognition underscores the dedication and leadership of SLU's nurse educators in advancing the profession and shaping the future of health care.
- William S. Sly, M.D.: 1932-2025William S. Sly, M.D., professor emeritus of Biochemistry and Molecular Biology at Saint Louis University School of Medicine, died Saturday, May 31, 2025. He was 92. An alumnus of Saint Louis University, Sly was an internationally known physician and scientist. He is perhaps best known for his work on the disease that now bears his name - Sly syndrome, also called mucopolysaccharidosis type VII (MPS-VII). His research team described the first patient with the disease, and later he helped develop an FDA-approved treatment.
